Apella Capital LLC Boosts Holdings in Doximity, Inc. (NASDAQ:DOCS)

Apella Capital LLC increased its position in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 10.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 69,320 shares of the company's stock after acquiring an additional 6,553 shares during the period. Apella Capital LLC's holdings in Doximity were worth $3,701,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. GAMMA Investing LLC increased its stake in shares of Doximity by 20.6% in the 4th quarter. GAMMA Investing LLC now owns 1,735 shares of the company's stock worth $93,000 after purchasing an additional 296 shares in the last quarter. MetLife Investment Management LLC increased its position in Doximity by 0.6% in the third quarter. MetLife Investment Management LLC now owns 65,064 shares of the company's stock worth $2,835,000 after buying an additional 363 shares in the last quarter. First Horizon Advisors Inc. raised its stake in shares of Doximity by 22.5% in the third quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company's stock worth $91,000 after buying an additional 384 shares during the period. Farther Finance Advisors LLC raised its stake in shares of Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock worth $34,000 after buying an additional 603 shares during the period. Finally, KBC Group NV lifted its position in shares of Doximity by 22.9% during the 3rd quarter. KBC Group NV now owns 3,296 shares of the company's stock valued at $144,000 after buying an additional 614 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on DOCS. JPMorgan Chase & Co. raised their target price on shares of Doximity from $30.00 to $48.00 and gave the stock a "neutral" rating in a research note on Thursday, November 21st. Stephens began coverage on shares of Doximity in a research note on Friday, December 20th. They set an "equal weight" rating and a $55.00 target price on the stock. Barclays upped their target price on shares of Doximity from $52.00 to $75.00 and gave the stock an "overweight" rating in a report on Monday, November 11th. Robert W. Baird raised their price target on Doximity from $41.00 to $45.00 and gave the company an "outperform" rating in a report on Tuesday, September 17th. Finally, Canaccord Genuity Group reaffirmed a "hold" rating and issued a $60.00 price objective (up previously from $40.00) on shares of Doximity in a research note on Wednesday, November 13th. Thirteen equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $53.12.

Doximity Price Performance

Shares of NASDAQ DOCS traded up $2.25 during mid-day trading on Wednesday, hitting $53.02. 961,183 shares of the company's stock traded hands, compared to its average volume of 1,490,308. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $61.75. The company's 50-day moving average is $53.40 and its two-hundred day moving average is $42.09. The company has a market capitalization of $9.90 billion, a P/E ratio of 60.94, a PEG ratio of 4.13 and a beta of 1.38.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.